SCHEMBL7737636

SCHEMBL7737636

CCC1Cc2ccccc2C1(N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.37
LMNA P02545 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6690927 0.85 GRM2 (0.41) SIGMAR1LMNABLM
SCHEMBL18260436 0.80 ACHE (0.45)
SCHEMBL24209562 0.78 ARG1 (0.49)
SCHEMBL6071126 0.76 GAA (0.40) LMNABLM
SCHEMBL7426458 0.72 L3MBTL1 (0.40)
SCHEMBL9422156 0.72 SIGMAR1 (0.40) SIGMAR1
SCHEMBL6716717 0.71 EPHX2 (0.37) LMNABLM
SCHEMBL306308 0.71 EPHX2 (0.37) LMNABLM
SCHEMBL6716719 0.71 EPHX2 (0.37) LMNABLM
SCHEMBL10272560 0.71 SIGMAR1 (0.35) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699909-B1 MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS PRESCIENT NEUROPHARMA INC. (CA) 2004-03-02 US disclosed